CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Molecular Insight Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 29, 2022Heterodimers Of Glutamic Acid1
Dec 30, 2020Heterodimers Of Glutamic Acid3

Top competitors of Molecular Insight Pharmaceuticals

Top competitors of Molecular Insight Pharmaceuticals based on patent oppositions.